DRGT-59

N/A

Report date: 2023/04/25 09:11:29

Base Information

Drug NameDRGT-59
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSerotonin (5-HT) receptor antagonists
TargetsSerotonin (5-HT) receptor
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTavanta Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTavanta Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksN/A